These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 21446778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP, Ageno W, Beenen LF, Brenner B, Buller HR, Chen CZ, Cohen AT, Grosso MA, Meyer G, Raskob G, Segers A, Vanassche T, Verhamme P, Wells PS, Zhang G, Weitz JI.
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
    Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR, Hokusai-VTE investigators.
    Lancet Haematol; 2016 Aug; 3(8):e379-87. PubMed ID: 27476789
    [Abstract] [Full Text] [Related]

  • 5. Edoxaban, a Novel Oral Factor Xa Inhibitor.
    Minor C, Tellor KB, Armbruster AL.
    Ann Pharmacother; 2015 Jul; 49(7):843-50. PubMed ID: 25855704
    [Abstract] [Full Text] [Related]

  • 6. Edoxaban in the prevention and treatment of thromboembolic complications from a clinical point of view.
    Barrios V, Escobar C.
    Expert Rev Cardiovasc Ther; 2015 Jul; 13(7):811-24. PubMed ID: 26068539
    [Abstract] [Full Text] [Related]

  • 7. Edoxaban: a new oral direct factor xa inhibitor.
    Camm AJ, Bounameaux H.
    Drugs; 2011 Aug 20; 71(12):1503-26. PubMed ID: 21861537
    [Abstract] [Full Text] [Related]

  • 8. Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practice.
    Barrios V, Escobar C.
    Future Cardiol; 2016 Jul 20; 12(4):419-33. PubMed ID: 27121025
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
    Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E.
    Am Heart J; 2010 Oct 20; 160(4):635-41. PubMed ID: 20934556
    [Abstract] [Full Text] [Related]

  • 14. [Hokusai-VTE: edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism].
    Sprynger M.
    Rev Med Liege; 2013 Oct 20; 68(10):548-51. PubMed ID: 24298731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral anticoagulation with edoxaban.
    Ahrens I, Bode C.
    Hamostaseologie; 2012 Oct 20; 32(3):212-215. PubMed ID: 29589362
    [Abstract] [Full Text] [Related]

  • 18. Direct factor Xa inhibitor edoxaban: from bench to clinical practice.
    Brekelmans M, Middeldorp S, Coppens M.
    Expert Rev Hematol; 2015 Dec 20; 8(6):707-25. PubMed ID: 26560872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Edoxaban: Review of pharmacology and key phase I to III clinical trials.
    Plitt A, Giugliano RP.
    J Cardiovasc Pharmacol Ther; 2014 Sep 20; 19(5):409-16. PubMed ID: 24607764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.